Last reviewed: May 14, 2026 Last updated: May 14, 2026 Written by: Jay Hastings , CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Research Finding: Published Science Liposomal glutathione bypasses the digestive degradation faced by conventional glutathione, facilitating direct cytosolic delivery and allowing immediate replenishment of the intracellular thiol pool
This treatment successfully induced senescence, as evidenced by a significant increase in SA--gal activity
More than 90% of participants on the combination lost 5% of body weight, and more than half lost 20%
EVIDENCE GRADES 12-week Metabolic Pharmaceuticals Phase 2b at 1 mg/day did not meet primary weight-loss endpoint
Disclaimer: This website connects patients with licensed healthcare providers who can evaluate medical conditions and prescribe medications when appropriate